|
ResMed Inc. (RMD) DCF Valuation
US | Healthcare | Medical - Instruments & Supplies | NYSE
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
ResMed Inc. (RMD) Bundle
Explore the financial prospects of ResMed Inc. (RMD) with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and expenses to calculate the intrinsic value of ResMed Inc. (RMD) and inform your investment strategy.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,957.0 | 3,196.8 | 3,578.1 | 4,223.0 | 4,685.3 | 5,259.3 | 5,903.7 | 6,627.0 | 7,438.9 | 8,350.3 |
| Revenue Growth, % | 0 | 8.11 | 11.93 | 18.02 | 10.95 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 |
| EBITDA | 990.4 | 1,099.2 | 1,176.6 | 1,358.8 | 1,533.5 | 1,742.6 | 1,956.1 | 2,195.8 | 2,464.8 | 2,766.8 |
| EBITDA, % | 33.49 | 34.38 | 32.88 | 32.18 | 32.73 | 33.13 | 33.13 | 33.13 | 33.13 | 33.13 |
| Depreciation | 181.4 | 191.5 | 193.8 | 196.5 | 216.2 | 282.0 | 316.6 | 355.3 | 398.9 | 447.7 |
| Depreciation, % | 6.13 | 5.99 | 5.42 | 4.65 | 4.61 | 5.36 | 5.36 | 5.36 | 5.36 | 5.36 |
| EBIT | 809.1 | 907.7 | 982.8 | 1,162.3 | 1,317.3 | 1,460.6 | 1,639.6 | 1,840.4 | 2,065.9 | 2,319.0 |
| EBIT, % | 27.36 | 28.39 | 27.47 | 27.52 | 28.12 | 27.77 | 27.77 | 27.77 | 27.77 | 27.77 |
| Total Cash | 463.2 | 295.3 | 273.7 | 227.9 | 238.4 | 452.6 | 508.1 | 570.4 | 640.2 | 718.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 484.1 | 614.3 | 576.0 | 704.9 | 837.3 | 907.2 | 1,018.3 | 1,143.1 | 1,283.2 | 1,440.4 |
| Account Receivables, % | 16.37 | 19.22 | 16.1 | 16.69 | 17.87 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
| Inventories | 416.9 | 457.0 | 743.9 | 998.0 | 822.3 | 950.6 | 1,067.0 | 1,197.7 | 1,344.5 | 1,509.2 |
| Inventories, % | 14.1 | 14.3 | 20.79 | 23.63 | 17.55 | 18.07 | 18.07 | 18.07 | 18.07 | 18.07 |
| Accounts Payable | 135.8 | 138.0 | 159.2 | 150.8 | 237.7 | 231.4 | 259.8 | 291.6 | 327.4 | 367.5 |
| Accounts Payable, % | 4.59 | 4.32 | 4.45 | 3.57 | 5.07 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 |
| Capital Expenditure | -105.9 | -116.8 | -156.0 | -134.0 | -114.9 | -181.2 | -203.4 | -228.3 | -256.2 | -287.6 |
| Capital Expenditure, % | -3.58 | -3.65 | -4.36 | -3.17 | -2.45 | -3.44 | -3.44 | -3.44 | -3.44 | -3.44 |
| Tax Rate, % | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 |
| EBITAT | 686.1 | 487.4 | 797.5 | 946.9 | 1,063.4 | 1,115.4 | 1,252.1 | 1,405.5 | 1,577.7 | 1,771.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -3.7 | 394.0 | 608.1 | 617.9 | 1,295.1 | 1,011.8 | 1,166.1 | 1,308.9 | 1,469.3 | 1,649.3 |
| WACC, % | 7.61 | 7.57 | 7.61 | 7.61 | 7.61 | 7.6 | 7.6 | 7.6 | 7.6 | 7.6 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 5,237.7 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 1,715 | |||||||||
| Terminal Value | 47,633 | |||||||||
| Present Terminal Value | 33,024 | |||||||||
| Enterprise Value | 38,262 | |||||||||
| Net Debt | 636 | |||||||||
| Equity Value | 37,626 | |||||||||
| Diluted Shares Outstanding, MM | 148 | |||||||||
| Equity Value Per Share | 255.00 |
What You Will Get
- Real RMD Financial Data: Pre-filled with ResMed’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See ResMed’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- 🔍 Real-Life RMD Financials: Pre-filled historical and projected data for ResMed Inc. (RMD).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate ResMed’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize ResMed’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Open the Template: Download and open the Excel file containing ResMed Inc.'s (RMD) preloaded data.
- 2. Edit Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures.
- 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV based on your inputs.
- 4. Test Scenarios: Evaluate various forecasts to analyze different valuation outcomes for ResMed Inc. (RMD).
- 5. Use with Confidence: Present professional valuation insights to inform your investment decisions regarding ResMed Inc. (RMD).
Why Choose This Calculator for ResMed Inc. (RMD)?
- Precise Information: Authentic ResMed financials guarantee trustworthy valuation outcomes.
- Tailorable: Modify essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Efficiency Boost: Ready-made calculations save you the effort of starting from the ground up.
- Expert-Level Tool: Crafted for investors, analysts, and consultants in the healthcare sector.
- Easy to Use: User-friendly design and clear instructions ensure accessibility for everyone.
Who Should Use This Product?
- Healthcare Professionals: Develop comprehensive valuation models for assessing ResMed Inc. (RMD) investments.
- Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Financial Consultants: Deliver precise valuation insights related to ResMed Inc. (RMD) for client advisement.
- Students and Instructors: Utilize real-world financial data to enhance learning and practice in financial modeling.
- Market Analysts: Gain insights into how healthcare technology companies like ResMed Inc. (RMD) are valued in the investment landscape.
What the ResMed Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for ResMed Inc. (RMD).
- Real-World Data: ResMed’s historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into ResMed's performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to ResMed Inc. (RMD).
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for decision-making.